Bright Light Therapy for Depressed Geriatric Inpatients
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT07002554
- Phase
- PHASE2
- Status
- Enrolling By Invitation
Conditions
- Unipolar Depression
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bright light therapy — DEVICEthe Verilux® HappyLight® Lumi Plus light therapy box, which delivers UV-free, full-spectrum LED light at an intensity of 10,000 lux
- dim red light — DEVICEThe control group will use the same light box device, configured to emit dim red light. This will be achieved by setting the box to its lowest brightness setting and overlaying a translucent red filter over the light display. This setup is intended to maintain the appearance and experience of light exposure while minimizing any therapeutic effect.
Study Details
Bright light therapy has been shown to be effective for the treatment of both seasonal and non-seasonal unipolar depression as well as bipolar depression, primarily in outpatients under the age of 60. There is a dearth of studies exploring the efficacy of this treatment modality among elderly depressed inpatients, which is our study population.
Key Dates
- Start date
- Nov 14, 2025
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Bright light therapyParticipants in the intervention group will receive bright light therapy (BLT) consisting of 10,000 lux of bright white light administered for 30 minutes each morning, ideally within 30 minutes of awakening. Participants in both arms will continue to receive other treatment as usual (group therapy and medication management) as deemed appropriate by their treating clinicians.
- Sham Comparator: Dim Red lightParticipants in the control group will receive a placebo condition using an identical light box fitted with a translucent red screen to emit dim red light at an intensity of less than 2,500 lux, which lacks efficacy for depression treatment based on prior research. Participants in both arms will continue to receive other treatment as usual (group therapy and medication management) as deemed appropriate by their treating clinicians.
Primary Outcome Measure
Study completion rate [ Time Frame: Up to week 6 (Upon time of discharge from inpatient unit) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina Institute of Psychiatry Senior Care Unit | Charleston | South Carolina | 29425 | - |
Find similar trials in Charleston, SC
Related Studies
- Effect of Tao Calligraphy Meditation and Energized Water on DepressionRecruiting · Sha Research Foundation · Kahului, Hawaii
- Transcranial Direct Current Stimulation for DepressionRecruiting · Soterix Medical · Woodbridge, New Jersey
- Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung CancerPHASE2 · Recruiting · Alan Davis · Columbus, Ohio
- RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)PHASE4 · Recruiting · Mayo Clinic · Rochester, Minnesota